Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Jacobs

Showing results (111-120 of 184) with videos related to

Pageof 19
Sort By:
Journal of Medical Genetics|May 31, 2015
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsSarah Jervis, Honglin Song, Andrew Lee, et al.
Clinical Chemistry|February 17, 2007
Preanalytic influence of sample handling on SELDI-TOF serum protein profilesJohn F Timms, Elif Arslan-Low, Aleksandra Gentry-Maharaj, et al.
American Journal of Obstetrics and Gynecology|July 11, 2017
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestryRanjit Manchanda, Shreeya Patel, Antonis C Antoniou, et al.
BMJ (Clinical Research Ed.)|July 13, 2018
Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observationCarrie L Williams, Michael E Jones, Anthony J Swerdlow, et al.
British Journal of Cancer|July 1, 2017
A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumoursMatthew R Russell, Ciaren Graham, Alfonsina D'Amato, et al.
BMC Public Health|November 18, 2017
Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey studySusanne F Meisel, Maddie Freeman, Jo Waller, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2012
Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomyRanjit Manchanda, Anna Silvanto, Ahmed Abdelraheim, et al.
Gynecologic Oncology|October 18, 2011
Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS)Kate J Lifford, Lindsay Fraser, Adam N Rosenthal, et al.
Endocrine-Related Cancer|December 27, 2011
Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal womenEvangelia-Ourania Fourkala, Alexey Zaikin, Matthew Burnell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profilingAli Tiss, John F Timms, Celia Smith, et al.
Pageof 19

Showing results (111-120 of 184) with videos related to

Sort By:
Pageof 19
Journal of Medical Genetics|May 31, 2015
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsSarah Jervis, Honglin Song, Andrew Lee, et al.
Clinical Chemistry|February 17, 2007
Preanalytic influence of sample handling on SELDI-TOF serum protein profilesJohn F Timms, Elif Arslan-Low, Aleksandra Gentry-Maharaj, et al.
American Journal of Obstetrics and Gynecology|July 11, 2017
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestryRanjit Manchanda, Shreeya Patel, Antonis C Antoniou, et al.
BMJ (Clinical Research Ed.)|July 13, 2018
Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observationCarrie L Williams, Michael E Jones, Anthony J Swerdlow, et al.
British Journal of Cancer|July 1, 2017
A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumoursMatthew R Russell, Ciaren Graham, Alfonsina D'Amato, et al.
BMC Public Health|November 18, 2017
Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey studySusanne F Meisel, Maddie Freeman, Jo Waller, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2012
Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomyRanjit Manchanda, Anna Silvanto, Ahmed Abdelraheim, et al.
Gynecologic Oncology|October 18, 2011
Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS)Kate J Lifford, Lindsay Fraser, Adam N Rosenthal, et al.
Endocrine-Related Cancer|December 27, 2011
Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal womenEvangelia-Ourania Fourkala, Alexey Zaikin, Matthew Burnell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profilingAli Tiss, John F Timms, Celia Smith, et al.
Pageof 19